Professional Documents
Culture Documents
If you no longer wish to receive this free newsletter, CLICK HERE to unsubscribe
The ValuEngine Weekly is an Investor Education newsletter focused on the quantitative approach to
investing and the tools available from In today's fast-moving and globalized financial markets, it is easy to
get overloaded with information. The winners will adopt an objective, scientific, independent and
unemotional approach to investing. If you are not yet a member of ValuEngine's stock analysis service,
sign up now for a two-week free trial at www.valuengine.com!
Started week
Friday AM
Change
Change %
ytd
DJIA
19872.86
19961.22
88.36
0.44%
14.55%
NASDAQ
5425.62
5520.89
95.27
1.76%
10.25%
RUSSELL 2000
1357.99
1370.94
12.95
0.95%
20.69%
S&P 500
2251.57
2277.26
25.69
1.14%
11.42%
33.96%
Stocks Overvalued
66.04%
14.01%
30.66%
SECTOR OVERVIEW
Sector
Change
MTD
YTD
Valuation
Last 12-M
Return
P/E
Ratio
Aerospace
0.07%
2.44%
2.44%
14.80% overvalued
12.93%
20.78
Auto-Tires-Trucks
-0.84%
1.73%
1.73%
7.86% overvalued
26.38%
15.03
Basic Materials
0.66%
4.03%
4.01%
13.83% overvalued
76.17%
27.92
Business Services
-0.27%
0.84%
0.84%
10.65% overvalued
12.72%
24.46
-0.48%
1.47%
2.05%
8.39% overvalued
15.04%
30.97
Construction
-0.23%
1.76%
1.76%
11.77% overvalued
25.20%
21.67
Consumer Discretionary
0.05%
1.53%
1.53%
5.02% overvalued
18.72%
23.84
Consumer Staples
0.11%
1.04%
1.04%
5.98% overvalued
11.88%
24.13
Finance
-0.47%
1.19%
1.19%
16.14% overvalued
16.19%
18.24
Industrial Products
-0.90%
1.29%
1.29%
17.87% overvalued
25.54%
24.72
Medical
-0.10%
3.48%
3.48%
5.90% undervalued
-7.78%
28.51
Multi-Sector Conglomerates
-0.18%
1.51%
1.51%
17.56% overvalued
15.91%
19.98
Oils-Energy
0.20%
2.80%
2.80%
20.91% overvalued
29.12%
26.8
Retail-Wholesale
-1.50%
1.33%
1.33%
3.33% overvalued
6.52%
23.13
Transportation
-0.43%
2.31%
2.31%
10.59% overvalued
12.36%
18.36
Utilities
-0.13%
2.53%
2.53%
11.37% overvalued
19.43%
22.03
Sector TalkMedical
Below, we present the latest data on leading Medical Sector stocks from our
Professional Stock Analysis Service. We applied some basic liquidity criteria--share
price greater than $3 and average daily volume in excess of 100k shares. We have
been following the sector closely of late because it has been correlated so tightly to
overall equity price moves.
Company Name
Market Price
Valuation
LNTH
LANTHEUS HLDGS
8.3
N/A
158.57%
ANIP
ANI PHARMACEUT
62.63
20.53%
40.58%
HCA
HCA HOLDINGS
76.81
-13.18%
15.61%
HMNY
HELIOS&MATHESON
3.4
N/A
108.40%
SCLN
SCICLONE PHARMA
10.8
N/A
26.32%
Company Name
Market Price
Valuation
CRBP
CORBUS PHARMACT
8.3
N/A
440.33%
CLCD
COLUCID PHARMA
32.95
N/A
284.48%
CTIC
CTI BIOPHARMA
4.46
117.62%
251.18%
EXEL
EXELIXIS INC
14.99
95.06%
184.71%
TSRO
TESARO INC
138.59
258.81%
181.63%
Company Name
Market Price
Valuation
HCA
HCA HOLDINGS
76.81
-13.18%
15.61%
ABBV
ABBVIE INC
63.77
1.92%
11.16%
HLS
HEALTHSOUTH CP
41.5
-3.97%
19.42%
JNJ
116.86
0.56%
15.82%
ZBH
ZIMMER BIOMET
104.95
-14.90%
0.98%
Company Name
Market Price
Valuation
AEZS
AETERNA ZENTARS
300.00%
-28.74%
TSRO
TESARO INC
138.59
258.81%
181.63%
AKAO
ACHOGEN INC
14.7
254.72%
153.89%
CYH
COMMNTY HLTH SY
6.27
188.82%
-75.97%
CHRS
COHERUS BIOSC
28
164.30%
35.99%
Find out what Wall Street Investment and Media Professionals already know,
ValuEngine offers sophisticated stock valuation and forecast research as well as a
variety of portfolio screening and creation tools.
ValuEngine Forecast
Target
Price*
Expected
Return
1-Month
120.82
0.31%
3-Month
122.04
1.33%
6-Month
121.53
0.90%
1-Year
124.99
3.78%
2-Year
136.53
13.36%
3-Year
132.30
9.85%
7.43% overvalued
Valuation Rank(?)
0.31%
12-M Return
-0.58%
Momentum Rank(?)
53
75
32
Sharpe Ratio
0.63
83
11.45%
75
Volatility
18.19%
Volatility Rank(?)
-3.10%
189.43
Size Rank
11.31
11.67
75
16
100
90
78
PEG Ratio
n/a
Price/Sales
0.77
Price/Sales Rank(?)
76
Market/Book
1.11
Market/Book Rank(?)
76
Beta
0.82
Beta Rank
Alpha
-0.12
Alpha Rank
n/a
51
27
A total of eleven additional firm specific variables are also used. The
ValuEngine View portfolio is constructed by integrating both our Aggressive
Growthbased on the Valuation Model--and Diversified Growthbased on
the Forecast Model-- Portfolio Strategies.
The ValuEngine View Strategy is constructed by integrating this model along
with some basic rules for market capitalization and industry diversification. The
portfolio has 15 stocks and is rebalanced once each month.
Strategies To Suit All Investor Types
The ValuEngine Diversified Strategy: The ValuEngine Diversified Strategy
invests in a variety of asset classes in order to provide investors with stable
returns and a high- dividend yield coupled with significantly lower risk than
single-asset products.
The ValuEngine Diversified Strategy may include ETFs focused on commodities,
stock indices, REITS, bonds, emerging markets, and other suitable products.
By reaping the benefits of diversification, the ValuEngine Diversified Strategy
seeks to remain resilient during times of market volatility.
The ValuEngine Diversified Strategy is designed for investors seeking
management for their IRA and other retirement funds as well as those whose
risk-profile is not suitable for our other strategies.
Please contact us if you would like to put the power of ValuEngine to work
for you at the new full-service money management firm-ValuEngine Capital
For more information, please contact ValuEngine Capital by email at
info@ValuEngineCapital.com or by phone at (407) 308-5686.
Or, sign up online with the easy-to-use portal HERE: